FDAnews Device Daily Bulletin

CLX INVESTMENT COMPANY ANNOUNCES SHIPMENTS OF INFECTIOUS DISEASE TESTS TO EUROPEAN MARKETS

Dec. 15, 2005
A A

CLX Investment Company, Inc. today announced that portfolio investment Zonda, Inc. is continuing shipments of its HandiLab-C test for Chlamydia to European markets. A shipment of the personal use (over-the-counter) Chlamydia-C test was sent to the company's distributor for Scandinavia in late November for delivery to pharmacies across Norway.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051214005429&newsLang=en)